Minnesota covered entities will have additional 340B reporting requirements this year, but an extended deadline to submit that data, according [...] …
Articles by : Bella Czajkowski, National Correspondent
Tariffs on Pharmaceuticals Could Worsen Drug Shortages, Cause Disarray in 340B Prices, Advocates Say
President Donald Trump’s (R) plan to place tariffs on foreign pharmaceuticals could destabilize 340B drugs’ prices unless drugmakers absorb the [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
SK Life Science recently issued a refund notice for an epilepsy drug following a 340B price ceiling recalculation. The New [...] …
Johnson & Johnson (J&J) added Ustekinumab, the unbranded version of psoriatic arthritis treatment Stelara, to its 340B contract pharmacy restrictions [...] …
A shuttered Philadelphia-area hospital recently amended its legal filing in a class action case against CVS Health’s (CVS) contract pharmacy [...] …
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws, 340B [...] …
Virginia Gov. Glenn Youngkin (R) signed a bill this week that will expand the state’s existing 340B pharmacy benefit manager [...] …
Drugmakers Merck and Novartis recently updated their 340B contract pharmacy restrictions, modifying what states are exempt from such policies following [...] …
The Trump administration this week continued to oppose drug industry attempts to unilaterally convert 340B discounts to a rebate model, [...] …